STOCK TITAN

Paul Rubin reports three 7,433-share sales (BIOA) in Form 144

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

BIOA Rule 144 notice: The filing lists proposed and recent sales of Common stock under Rule 144. It shows three reported sales by Paul Rubin of 7,433 shares each on 01/02/2026, 02/02/2026, and 03/02/2026 with dollar proceeds reported for each sale. The filing also lists securities to be sold on 04/01/2026 connected to options granted on 07/01/2020 and 05/29/2022.

Positive

  • None.

Negative

  • None.
Sale by Paul Rubin (Jan 2, 2026) 7,433 shares sale dated 01/02/2026 with proceeds $95,490.42
Sale by Paul Rubin (Feb 2, 2026) 7,433 shares sale dated 02/02/2026 with proceeds $139,368.75
Sale by Paul Rubin (Mar 2, 2026) 7,433 shares sale dated 03/02/2026 with proceeds $148,882.99
To be sold (option granted 07/01/2020) 5,437 shares listed for sale on 04/01/2026 tied to option granted 07/01/2020
To be sold (option granted 05/29/2022) 3,383 shares listed for sale on 04/01/2026 tied to option granted 05/29/2022
Brokerage reference 8,820 (shares listed) Fidelity Brokerage Services LLC entry dated 04/01/2026
Rule 144 regulatory
"lists proposed and recent sales of Common stock under Rule 144"
Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.
Option Granted financial
"Option Granted 07/01/2020"
Cash Common financial
"04/01/2026 | Cash Common"
Securities To Be Sold regulatory
"144: Securities To Be Sold"

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What sales does the BIOA Form 144 report?

The filing reports three sales by Paul Rubin of 7,433 shares each. Reported sale dates are 01/02/2026, 02/02/2026, and 03/02/2026, with proceeds listed as $95,490.42, $139,368.75, and $148,882.99 respectively.

Are any securities listed as to-be-sold on BIOA's Form 144?

Yes. The filing lists securities to be sold on 04/01/2026 tied to options: one line shows 5,437 shares (option granted 07/01/2020) and another shows 3,383 shares (option granted 05/29/2022).

Who is listed as the broker or intermediary in the BIOA filing?

Fidelity Brokerage Services LLC is referenced with an address in Smithfield, RI. The entry includes an apparent share count of 8,820 associated with Fidelity on 04/01/2026 in the securities section of the filing.

Do the Form 144 entries indicate the sale method or cash treatment for BIOA shares?

The filing shows the disposition type as Cash for the listed securities to be sold on 04/01/2026. No additional plan or placement method details are provided in the excerpt.